Streamlining Anthem (Elevance Health) Prior Authorization for Infectious Disease

Navigating Anthem (Elevance Health) prior authorization for infectious disease treatments requires a deep understanding of payer-specific channels and clinical criteria to ensure timely patient access to critical therapies.

Infectious disease prior authorizations, particularly for high-cost antivirals, antifungals, and Outpatient Parenteral Antibiotic Therapy (OPAT), present unique challenges for revenue cycle directors and PA coordinators. Klivira provides a clear pathway to manage Anthem (Elevance Health) PA requirements, integrating with your EMR to streamline submissions and reduce administrative burden.

Anthem's Prior Authorization Channels for Infectious Disease Therapies

Anthem-licensed plans utilize distinct channels for medical and pharmacy benefit prior authorizations. Medical benefit requests, common for OPAT and certain infusible antivirals, are typically routed through Availity Essentials, Anthem's primary multi-payer provider workspace. Pharmacy benefit PAs, covering many oral antivirals and antifungals, are managed by CarelonRx (Elevance Health's PBM) and support ePA submissions via CoverMyMeds and Surescripts.

Key Infectious Disease Treatments Requiring Anthem PA

High-cost antivirals, including regimens for Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV)
Advanced antifungal therapies for systemic infections
Outpatient Parenteral Antibiotic Therapy (OPAT) for prolonged intravenous antibiotic administration
Specialty injectables and infusions for complex infectious conditions, subject to Anthem's site-of-care policies

Accessing Anthem Medical Policies and Clinical Criteria

For infectious disease treatments, Anthem operating companies publish medical policies and clinical utilization management guidelines through provider sites accessible via Availity. These policies detail the medical necessity criteria for specific drugs and services, often referencing Anthem-developed criteria or, in some cases, MCG guidelines. It is crucial to consult the specific state-licensed Anthem plan's policy index, noting the policy number and effective date.

Understanding Turnaround Times and Electronic PA Capabilities

Anthem's PA turnaround times for commercial plans are governed by state insurance regulations, which vary significantly. For Medicare Advantage, Medicaid managed care (e.g., Wellpoint), and QHP plans, Anthem is an impacted payer under CMS-0057-F, mandating 72-hour standard and 24-hour expedited decision timeframes on a phased compliance timeline. Klivira's platform supports X12 278 transactions for medical benefit PAs and integrates with ePA partners like CoverMyMeds and Surescripts for pharmacy benefit requests, aligning with Elevance Health's participation in Da Vinci Project initiatives.

Common Denial Patterns and Appeal Pathways for ID Services

Infectious disease prior authorizations with Anthem often face denials due to medical necessity, insufficient documentation, or failure to complete step therapy requirements, particularly for antivirals. Site-of-service mismatches are also common for OPAT. Denials are communicated via X12 277/835 transactions and Availity. Appeals for standard medical PAs follow the Anthem operating-company appeals process, with peer-to-peer reviews available for both medical and pharmacy benefit denials.

Frequently asked questions

How do I submit a prior authorization for OPAT with Anthem?

Prior authorization requests for Outpatient Parenteral Antibiotic Therapy (OPAT) with Anthem-licensed plans are typically submitted through Availity Essentials. This channel allows for the initiation of medical benefit PA requests, member benefit lookup, and the upload of necessary clinical documentation to support medical necessity.

Which ePA vendors does Anthem (CarelonRx) support for infectious disease medications?

For pharmacy benefit infectious disease medications, CarelonRx, Elevance Health's in-house PBM, supports electronic prior authorization (ePA) submissions through industry-standard platforms. Providers can utilize CoverMyMeds and Surescripts for prescriber-initiated workflows, streamlining the submission process for many oral antivirals and antifungals.

Where can I find Anthem's medical policies for HIV or HCV antivirals?

Anthem's medical policies for specific infectious disease treatments, including HIV and HCV antivirals, are published on the provider websites of the respective state-licensed Anthem operating companies. These are typically accessed via Availity. Ensure you reference the specific policy number, plan-state context, and effective date for accurate criteria.

What are common reasons for denial for infectious disease PAs with Anthem?

Common denial reasons for infectious disease prior authorizations with Anthem include insufficient documentation to support medical necessity, failure to adhere to step therapy protocols for certain drug classes, and site-of-service mismatches, particularly for services like OPAT. Denials may also occur if the procedure or drug is not covered under the specific state-plan benefit grid.

Does Anthem support X12 278 for medical benefit prior authorizations?

Yes, Anthem-licensed plans accept X12 278 transactions for medical benefit prior authorizations via clearinghouses. This electronic standard facilitates the submission and exchange of PA requests and responses, contributing to a more efficient workflow for providers integrating with platforms like Klivira.